PMA device
Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic Sealant
Baxter Healthcare Corp · Agent, Absorbable Hemostatic, Collagen Based (LMF, Class III) · First FDA decision Dec 12, 2000, newest Jul 10, 2001Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
7
Naming "Floseal Matrix"
MAUDE reports
0
Brand "Floseal Matrix", since 2015
PubMed studies
19
Mentioning "Floseal Matrix"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic Sealant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
P990009-S003 · Decided Jul 10, 2001 · 200 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- FLOSEAL MATRIX HEMOSTATIC SEALANTPMA supplement
P990009-S002 · Decided Dec 12, 2000 · 49 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Floseal Matrix", any status and sponsor, newest update first.
- Tract Closure in PCNLPivotal-lookingRecruiting
Icahn School of Medicine at Mount SinaiAcademic, hospital or other
NCT07668817 · 114 participants (planned) · Start Nov 2026 · Primary completion May 2028
Device: Floseal; Surgicel · For: Nephrolithiasis
Sites: New York, New York
University of AlbertaAcademic, hospital or other
NCT02488135 · 26 participants · Start Jul 1, 2015 · Primary completion Mar 1, 2017
Device: Floseal Hemostatic Matrix · For: Epistaxis
Sites: Edmonton, Canada
- Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled TrialCompleted
Yonsei UniversityAcademic, hospital or other
NCT04310150 · 80 participants · Start Feb 5, 2018 · Primary completion Mar 17, 2020
Device: Floseal · For: Coronary Artery Disease
Sites: Seoul, South Korea
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Floseal Matrix", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LMF
1,445 reports: 207 malfunction, 1,171 injury, 61 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0667-2024 · Started Dec 6, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).
Cause as FDA categorized it: Under Investigation by firm · Device type: Absorbable Collagen Hemostatic Agent With Thrombin (PMX)
Z-2957-2018 · Started May 30, 2018
Reason given: Baxter r recalled this device due to the use of an incorrect plastic formulation in the manufacture of the blue luer component of the FLOSEAL malleable tips.
Cause as FDA categorized it: Mixed-up of materials/components · Device type: Absorbable Collagen Hemostatic Agent With Thrombin (PMX)
Z-2340-2008 · Started Jul 31, 2008 · Posted by FDA Sep 20, 2008
Reason given: The recall is being conducted as a precautionary measure due to potential discoloration of the FloSeal material noted in six (6) non-medical complaints during delivery by the Endoscopic Applicator.
Cause as FDA categorized it: Pending · Device type: Agent, Absorbable Hemostatic, Collagen Based (LMF)
Published research
The most relevant PubMed records for "Floseal Matrix"[tiab]. The summary above synthesizes these.
- Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G, Piancone F, Bonifazi R, et al. · Ann Thorac Surg · 2009Comparative Study, Randomized Controlled Trial
- Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.
Lau AS, Upile NS, Lazarova L, et al. · Eur Arch Otorhinolaryngol · 2016
- FloSeal Matrix: new generation topical hemostatic sealant.
Oz MC, Rondinone JF, Shargill NS · J Card Surg · 2003
- The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study.
Testini M, Marzaioli R, Lissidini G, et al. · Langenbecks Arch Surg · 2009Comparative Study, Randomized Controlled Trial
- Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent.
Gall RM, Witterick IJ, Shargill NS, et al. · J Otolaryngol · 2002Clinical Trial, Research Support, Non-U.S. Gov't
- Applications of FloSeal in nephron-sparing surgery.
User HM, Nadler RB · Urology · 2003Comparative Study
- The use of FloSeal haemostatic sealant in the management of epistaxis: a prospective clinical study and literature review.
Wakelam OC, Dimitriadis PA, Stephens J · Ann R Coll Surg Engl · 2017Clinical Study
- A combination of hemostatic agents may safely replace deep medullary suture during laparoscopic partial nephrectomy in a pig model.
Ploussard G, Haddad R, Loutochin O, et al. · J Urol · 2015Research Support, Non-U.S. Gov't
- Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.
Weaver FA, Hood DB, Zatina M, et al. · Ann Vasc Surg · 2002Clinical Trial, Comparative Study
- Gelatin-thrombin Hemostatic Matrix-related Cyst Formation after Cerebral Hematoma Evacuation: A Report of Two Cases.
Yamaguchi I, Kanematsu Y, Shimada K, et al. · NMC Case Rep J · 2021Case Reports
- Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study.
Durrani OM, Fernando AI, Reuser TQ · Ophthalmic Plast Reconstr Surg · 2007Comparative Study
- Use of FloSeal matrix hemostatic agent in partial splenectomy after penetrating trauma.
Stacey MJ, Rampaul RS, Rengaragan A, et al. · J Trauma · 2008Case Reports
Other devices of this type
Also filed under product code LMF.
- SURGIFOAM® Absorbable Gelatin SpongeFerrosan Meidcal Devices A/S · PMA 2026
- Floseal Hemostatic MatrixBaxter Healthcare Corp · PMA 2015
- Vitagel Surgical HemostatStryker Corp. · PMA 2013
- SURGIFLO Hemostatic Matrix Kit with ThrombinFerrosan Meidcal Devices A/S · PMA 2025
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic SpongeIntegra LifeSciences Corporation · PMA 2019
- Instat Collagen Absorbable HemostatETHICON, Inc. · PMA 2007
- Avitene Flowable Collagen HemostatDavol Inc., Sub. C. R. Bard, Inc. · PMA 2025
- Collastat Absorbable Collagen Hemostatic AgentsIntegra LifeSciences Corporation · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.